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Shining a light on the dark secrets of the cell: synthetic proteins for better fluorescence 
imaging 
 
Curran Oi, Diana Tokarska and Lynne Regan 
 
Abstract 
 
The discovery of intrinsically fluorescent proteins revolutionized our ability to visualize 
proteins within living cells. Since that original observation, a plethora of fluorescent 
proteins with varied color and brightness have been obtained. For a number of imaging 
purposes, however, synthetic biology approaches have been required to create new 
labelling methodologies. Here we describe the protein engineering technologies that 
underlie some of those key designs and show how they have been used to great effect 
in different cell types. 
 
Introduction 
 
It is a grand challenge of biology to be able to see every molecule in the cell, and to 
track when and where they move. Proteins are responsible for the vast majority of 
functions in a cell, and consequently much research has focused on observing and 
tracking them. Ideally, we would be able to track multiple proteins, simultaneously, in 
live cells. Importantly, any method we use to label and track a protein must not change 
the latter’s behavior.  
 
The discovery of intrinsically fluorescent proteins (FPs) was game-changing and 
recognized by the 2008 Nobel Prize. Prior to their discovery, essentially the only way to 
observe a protein in a cell was to chemically fix (i.e. kill and immobilize) cells, then 
visualize specific proteins by immunofluorescence. FPs mature and fluoresce without 
the requirement for any other proteins or small molecule co-factors. Thus, they can be 
produced in virtually any cell and will spontaneously fold and fluoresce, in the live cell. 
Thankfully, many proteins tolerate being genetically fused to a FP without any impact on 
their function. Figure 1 (A, B) shows two beautiful examples of intracellular proteins 
directly fused, at the gene level, to FPs and visualized by fluorescence microscopy.  
  
Sometimes, however, such fusions do perturb function, or are not compatible with the 
types of measurement researchers wish to make. In these situations, a battery of 
different protein engineering and synthetic biology approaches can be used. Here we 
describe several approaches of this kind and show how they have been applied to 
overcome a variety of limitations associated with direct fusions (Figure 2A). 
 
The first FP was green fluorescent protein (GFP) but an abundance of new FPs with 
different colors and properties have subsequently been discovered in new species or 
created in the laboratory using mutagenesis combined with screening. Consequently, 
we now have a large repertoire of different FPs.  
The minimum prerequisite for a FP to be genetically fused to a natural protein, without 
perturbing its function, is that the FP is monomeric. Many naturally occurring FPs tend 
to be dimers or tetramers, so mutagenesis was required to create synthetic, monomeric 
proteins. Without this intervention, FPs associate into higher order structures, dragging 
along the protein to which it is fused and change the localization and properties of the 
protein under investigation. Researchers have found that this phenomenon can be 
particularly severe when membrane proteins are fused to a FP that weakly self-
associates. When such FPs are fused to soluble proteins, their weak propensity to 
associate can be insignificant, but when fused to a membrane protein the local 
concentration is much higher, and the ‘weak’ association becomes a serious issue. 
 
How can creating new synthetic proteins expand the range of applications of FPs even 
more? Although direct fusion to a monomeric FP works well for many proteins, it does 
not work for all. For some proteins, especially membrane proteins, direct fusion to a FP 
prevents the protein from maturing and reaching its final functional location properly. In 
other situations, one wants to increase the signal from the protein of interest over the 
background fluorescence, or only track proteins that were labelled at a particular time. 
Protein engineering/synthetic biology approaches have created novel solutions to these 
issues. 
 
Post-translational labelling - covalent 
 
Hinrichsen and colleagues invented a strategy to covalently label proteins, post 
translationally, with a FP. In this strategy, they fused the protein of interest to a short 
peptide (SpyTag) and they expressed the FP fused, at the gene level, to SpyCatcher (or 
a related protein, for example SpyoIPD). The SpyTag-SpyCatcher system is an 
excellent example of re-engineering a natural protein to create a synthetic one that can 
be used in a variety of different applications. In the cell wall of the bacterium S. 
pyogenes, a covalent isopeptide bond forms spontaneously between the side-chains of 
a Lys and an Asp residue between two β strands in the CnaB2 domain of the protein 
FbaB. 
 
The SpyTag-SpyCatcher system was engineered by Howarth and colleagues, who 
showed that one of the β strands (SpyTag) could be completely removed from the 
protein FbaB, expressed separately, yet when it comes into contact with the remaining 
protein (SpyCatcher) it inserts and the covalent bond forms. Thus, any proteins that are 
fused to SpyCatcher and SpyTag become covalently linked (Figure 2C). This synthetic 
protein is a powerful addition to our in vivo engineering repertoire, because there are 
few other ways to covalently link two proteins, especially within living cells. 
 
Making use of this SpyTag-SpyCatcher system, Hinrichsen and colleagues expressed 
SpyCatcher-FP from an inducible promoter in Saccharomyces cerevisiae. They could 
thus control the timing and the amount of this protein produced. Using this strategy, they 
were able to post-translationally label a variety of proteins. Of particular note was the 
labelling of the membrane protein plasma membrane ATPase 1 (Pma1) - the main 
proton pump of the plasma membrane of S. cerevisiae. Direct fusions of Pma1 to a FP 
result in accumulation of the Pma1-FP in the vacuole (Figure 3B), with a concomitant 
growth defect. By labelling Pma1 post-translationally, both the vacuolar accumulation 
and growth defect were avoided. Thus, the true behavior of Pma1, in live cells, could be 
observed for the first time (Figure 3C). Moreover, because the labelling is covalent, by 
switching off production of SpyCatcher-FP, then spatiotemporally tracking the Pma1 
already covalently labelled with a FP, they were able to measure the lifetime of the 
protein in the membrane. 
 
How could the applications of such covalent post-translational labelling be expanded? 
Perhaps the most obvious extension of this method would be to label multiple proteins 
simultaneously. To accomplish such ‘multiplexed’ labelling, non-cross-reacting (also 
referred to as orthogonal) SpyCatcher/SpyTag pairs are needed. Veggiani and 
colleagues reported a different, naturally occurring protein-peptide pair, which they 
named SnoopCatcher/SnoopTag. SnoopCatcher and SpyCatcher are orthogonal, so 
this might have been the first such pair that could be used simultaneously with 
SpyTag/SpyCatcher in live cells. Unfortunately, SnoopCatcher spontaneously 
accumulates in the nucleus, which precludes its use in the desired fashion.  
 
It would also be useful if a set of different strength promoters were available, so that the 
level of expression of the labelling SpyCatcher-FP could be modulated. Dueber and 
colleagues described the systematic characterization of the strengths of different 
constitutive yeast promoters (11), which will be useful for post-translational in vivo 
labelling applications. To date, however, the repertoire of controllable (inducible) yeast 
promoters available is much more limited. Hinrichsen and colleagues used a GAL1 
promoter to control expression of SpyCatcher-FP, which makes the transcriptional 
response to galactose linear allowing a more gradual change in expression levels in 
response to different levels of induction. This work was done in a strain in which the 
GAL2 gene was deleted (gal2Δ). In a gal2Δ strain, the amount of protein expressed via 
the GAL1 promoter is linear with respect to the concentration of galactose in the growth 
media.   
 
Covalent post-translational labelling uniquely enables additional types of experiment to 
be performed. For example, if a Spy-Tagged protein is covalently labelled with 
SpyCatcher-FP expressed from a GAL1 promoter, expression from that promoter can 
be switched off by the addition of glucose. One can then spatiotemporally follow the fate 
of proteins that were labelled before the switch to glucose, for example measuring their 
lifetime without having to perturb the cell by adding cycloheximide (the translational 
inhibitor typically used in lifetime measurements). 
 
Enhancing Signal:Background 
 
In any fluorescent labelling and imaging, it is desirable to minimize background 
fluorescence. This background noise is a result of freely diffusing FPs, which are not 
bound to the protein of interest. 
 
Kamiyama and colleagues used a protein engineering strategy to optimize the signal to 
background, successfully reducing background fluorescence by ensuring that only the 
bound form of the FP was fluorescent. They accomplished this feat by creating a split 
version of super-folder GFP (sfGFP) in which one of the eleven β strands (GFP11) was 
expressed separately from the other ten (GFP1-10). When these two parts of the FP are 
separate, the protein is not fluorescent. When GFP11 binds to GFP1-10, the structure of 
the protein is complete, and is fluorescent (Figure 2D). Their ingenious solution was to 
fuse GFP11 to the target protein they wished to visualize and separately expressed 
GFP1-10.  
 
Because the non-bound form of the FP (GFP1-10) is not fluorescent, this method of 
labelling is quite forgiving with respect to the level of expression of the FP: High 
expression levels do not significantly increase background fluorescence.  
 
They were able to use this method to image several different proteins in mammalian 
cells and were able to expand this technique to multicolor imaging in a reasonably 
straightforward fashion by making the point mutations Y66W and T203Y in GFP1-10, 
thus creating CFP1-10 (cyan) and YFP1-10 (yellow), respectively.  
 
It is highly desirable to be able to perform multicolor imaging by simultaneously tagging 
multiple proteins in the cell with different colored fluorescent probes. Green and red are 
commonly used colors, because they are spectrally distinct, thus minimising bleed-
through across different excitation and emission filters used on microscopes.  
Kamiyama and colleagues therefore sought to expand their method to red FPs by 
applying the approach described above to mCherry (monomeric cherry) and sfCherry 
(super-folder cherry). The technique was not nearly so straightforward with these 
proteins as with sfGFP and sfGFP-derived FPs.  
 
Although co-expressing mCherry11 with mCherry1-10 resulted in increased fluorescence 
compared with expressing mCherry1-10 alone, the reconstituted fluorescent signal was 
far less than that of the original, un-split mCherry. Thus, additional engineering was 
required. The researchers first tried switching their efforts from mCherry to sfCherry. 
However, despite splitting and reconstituting sfCherry resulting in a higher intensity 
fluorescence than was observed for mCherry, it was not sufficiently bright to be useful in 
imaging applications. Similarly, the researchers achieved improved fluorescence 
intensity using tandem repeats of sfCherry11 fused, at the gene level, to a protein of 
interest, but the method was still not ideal for imaging applications (Figure 4). 
 
Feng and colleagues therefore developed a novel screening strategy for engineering 
new split FP with improved signal to background fluorescence levels. They performed 
multiple rounds of random mutagenesis and DNA shuffling, which propagates beneficial 
mutations using repeated cycles of DNA fragmentation and overlap polymerase chain 
reactions to reamplify the gene of interest. After each round of mutagenesis or DNA 
shuffling, they selected the brightest colonies as the source of template DNA for the 
next round. 
 
Using this approach, they were able to create two new split FPs: sfCherry21-10/11, which 
is 10-fold brighter than sfCherry1-10/11 (Figure 5) and can now be used in cell imaging 
applications in the same way that was so powerful for GFP1-10/11 and mNeonGreen21-
10/11, which is a yellow-green split FP that offers improved signal to background over 
GFP1-10/11 (Figure 6). 
 
Post-translational labelling - non-covalent 
 
For some applications, it is desirable to label the protein of interest neither by a direct 
fusion, nor by covalent, post-translational labelling, but via a non-covalent peptide: 
peptide-binding module-FP interaction (Figure 2B). 
 
There are several requirements for optimal operation of such a labelling strategy. First, 
the peptide-binding module-FP must not interact with other cellular proteins; it must bind 
the peptide that is fused to the protein of interest with high specificity. It is extremely 
hard to foresee whether a protein will have issues with promiscuous interactions. Highly 
positively-charged proteins, which may interact with DNA or the cell membrane, is one 
thing to avoid, but beyond such extremes, it is not predictable.  
 
Speltz and colleagues used a module that binds only to peptides with a free C-terminus. 
Thus, they were able to narrow down the possible cross-reactivity of their peptide-
binding modules by assessing the ‘C-terminome’ of the cell for sequences with few 
miss-matches to the peptide with which they were tagging the protein of interest. Even 
so, they experimentally tested their designs, assessing the ability of cell extracts to 
compete with the protein of interest in ‘pull down’ assays. They were able to identify 
three peptide:peptide-binding module pairs whose interaction is not abrogated by the 
interaction of either partner with cellular components. 
 
Additionally, if one seeks to label two proteins at once, the peptide:peptide-binding-
module pairs must not cross-react, they must be orthogonal to each other. Speltz et al. 
were able to create such pairs, using a combination of rational design and chemical 
intuition, combined with experimental assessment at every stage. 
 
Finally, if one is labelling a protein via a non-covalent interaction, it is vital to control the 
expression level of the peptide-binding module-FP relative to the dissociation constant 
of the peptide:peptide-binding module complex (Figure 7). If the expression level is too 
high, there will be excess, unbound binding module-FP and the background will be high. 
Conversely, if the expression level is too low, then not all the protein of interest will be 
bound to binding module-FP. 
 
One can use either constitutive promoters of different strengths, or well-controlled 
inducible promoters. In E. coli, the use of the arabinose promoter, from which 
transcription is linearly proportional to the concentration of inducing arabinose is one 
strategy. Similarly, in S. cerevisiae one can use a GAL1 promoter, in a gal2Δ 
background, to obtain a linear response of transcription versus concentration of 
galactose.  
 
New gene editing technologies will allow creative imaging experiments, such as those 
described above, to be implemented in mammalian cells. Currently, far fewer well-
characterized promoters are available for use in mammalian cells, though finding and 
testing more is a topic of much current investigation.  
 
Summary 
 
By utilising synthetic biology and protein engineering approaches, researchers have 
devised clever new ways to fluorescently label proteins for live cell imaging. Using 
different types of post-translational labelling, they have circumvented the perturbation of 
function sometimes associated with directly fusing a protein to a FP. They have also 
devised novel strategies for spatiotemporal tracking and for enhancing signal: 
background. In the future, we can anticipate expanding such approaches still further, as 
synthetic biology expands the range of constitutive and controllable promoters available 
to use in different cell types. In addition, we also envision new methods being 
developed to enable the researcher to track multiple proteins simultaneously, over time, 
and at ever higher resolution. Thus, the combination of synthetic biology and protein 
engineering provides new tools that enable us to better understand how cells work and 
move us towards meeting a grand challenge of biology.  
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Figure Legends 
Figure 1 
Fluorescence microscopy images of two different intracellular proteins directly fused, at the 
gene level, to FPs. Images are pseudocolored to match the emission profiles of the different 
FPs. (A) Actin with FP mTFP1 (a cyan FP) fused to its C-terminus. (B) Microtubule associated 
protein EB3 with FP YPet (a yellow FP) fused to its N-terminus. Adapted and reproduced with 
permission from Shaner NC, Patterson GH, Davidson MW. Advances in fluorescent protein 
technology. Journal of Cell Science. 2007;120(24):4247-60. 
 
Figure 2  
Comparison of different methods for fluorescently labelling a protein of interest. In all parts of 
the figure, the protein of interest is shown as a gray rectangle and the FP is shown as a bright 
green rectangle. 
(A) Direct fusion, at the gene level, of a FP to the protein of interest. 
(B) Non-covalent labelling of a protein of interest with a FP. The protein of interest is fused, at 
the gene level, to a short peptide tag (dark purple) and the FP is fused, at the gene level, to a 
peptide-binding module (light purple). Thus, the protein of interest is labelled by the non-
covalent interaction of the peptide with the binding module.  
(C) Covalent labelling of a protein of interest with a FP. 
The protein of interest is fused, at the gene level, to the SpyTag peptide (yellow) and the FP is 
fused, at the gene level, to the SpyCatcher protein (orange). Thus, the protein of interest is 
labelled by the covalent interaction of the peptide with the binding module. The covalent bond 
between SpyTag and Spycatcher is indicated by the red lock. Far right: ribbon representation of 
the x-ray crystal structure of the SpyTag/SpyCatcher complex (4MLI). The covalent isopeptide 
bond is indicated by red sticks. 
D) Labelling of a protein of interest by reassembly of a FP. The protein of interest is fused to a 
peptide that corresponds to a β strand (dark green bar) of a FP. The rest of the FP (light green) 
is expressed separately. Only when these two parts of the FP assemble is the protein 
fluorescent (bright green). Far right, a guide to the eye, based on the x-ray crystal structure of 
sfGFP (6DQ1), showing the β strand (dark green) that inserts into the remainder of the protein 
(pale green) to reconstitute a complete FP.  
 
Figure 3  
Comparison of different methods to visualize the plasma membrane protein Pma1.  
(A) Immuno-staining of fixed S. cerevisiae cells (using anti-HA antibodies, which target a 
peptide epitope derived from the human influenza hemagglutinin protein) in a strain expressing 
Pma1 fused, at the gene level, to the HA peptide. This ‘native’ Pma1 localizes exclusively to the 
plasma membrane. None is evident in the vacuole. Reproduced with permission from Mason 
AB, Allen KE, Slayman CW. C-terminal truncations of the Saccharomyces cerevisiae PMA1 H+-
ATPase have major impacts on protein conformation, trafficking, quality control, and function. 
Eukaryot Cell. 2014;13(1):43-52. 
(B) Live cell fluorescence imaging of S. cerevisiae expressing, from the endogenous Pma1 
promoter, a Pma1-EGFP (Enhanced GFP) fusion protein. A significant amount of fluorescence 
is observed in the vacuole, in addition to that at the plasma membrane.  
(C) Post-translational labelling of Pma1. Live cell fluorescent imaging of S. cerevisiae 
expressing Pma1-SpyTag from the endogenous Pma1 promoter. Pma1 was labelled by the 
covalent interaction of SpyTag with SpyCatcher-EGFP, which was expressed from the GAL1 
promoter. In this image, a post-labelling period of incubation with glucose was used, which 
enhances the signal: background.   
Reproduced with permission from Hinrichsen M, Lenz M, Edwards JM, Miller OK, Mochrie SGJ, 
Swain PS, et al. A new method for post-translationally labelling proteins in live cells for 
fluorescence imaging and tracking. Protein Eng Des Sel. 2017;30(12):771-80. 
 
Figure 4 
Increasing the fluorescence signal by using tandem repeats of sfCherry11.  
(A) Cartoon representation of the multiple tandem repeats method. The protein of interest (grey 
rectangle) is fused, at the gene level, to four tandem copies of β strand 11 of sfCherry 
(sfCherry11) (dark green ribbon) separated by short linkers. Thus, four molecules of sfCherry1-10 
can bind to this array, giving four sfCherry1-10/11 assembled proteins (bright green) attached to 
each protein of interest. 
(B) Comparing fluorescent images of β-actin labelled with single or multiple copies of sfCherry1-
10/11. Left: β-actin fused to a single sfCherry11. Right: β-actin fused to four tandem repeats of 
sfCherry11. In both scenarios, sfCherry1-10 is overexpressed from the constitutive 
cytomegalovirus (CMV) promoter. Scale bars are 5 μm.  
Reproduced with permission from Kamiyama D, Sekine S, Barsi-Rhyne B, Hu J, Chen B, Gilbert 
LA, et al. Versatile protein tagging in cells with split fluorescent protein. Nat Commun. 
2016;7:11046. 
 
Figure 5 
Comparing the whole cell fluorescence intensity (measured by flow cytometry) of HEK 293T 
cells expressing full length sfCherry, full length sfCherry2, assembled sfCherry1–10/11 or 
assembled sfCherry21–10/11, as indicated.  
Adapted and reproduced with permission from Feng S, Sekine S, Pessino V, Li H, Leonetti MD, 
Huang B. Improved split fluorescent proteins for endogenous protein labelling. Nat Commun. 
2017;8(1):370. 
 
Figure 6 
Labelling histone H2B (HB2) or clathrin light chain A (CLTA) using assembled split FP. Top left: 
H2B fused, at the gene level, to mNeonGreen211 (mNG211) with mNG21–10 expressed in trans 
from the CMV promoter. Top right: CTLA fused, at the gene level, to mNeonGreen211 (mNG211) 
with with mNG21–10 expressed in trans from the CMV promoter. Bottom left: H2B fused, at the 
gene level, to GFP11 H2B with GFP1–10 expressed in trans from the CMV promoter. Bottom right: 
CLTA fused, at the gene level, to GFP11 with GFP1–10 expressed in trans from the CMV 
promoter. Scale bars are 10 μm. Reproduced with permission from Feng S, Sekine S, Pessino 
V, Li H, Leonetti MD, Huang B. Improved split fluorescent proteins for endogenous protein 
labelling. Nat Commun. 2017;8(1):370. 
 
Figure 7 
Schematic illustration of the effect of expression level of the FP on signal:background when 
using non-covalent labelling strategies. Here, cell division control protein 12 (Cdc12), a protein 
involved in formation of the bud neck in S. cerevisiae is fused, at the gene level, to a peptide. A 
peptide binding module, fused, at the gene level, to a FP, is expressed at different levels. The 
signal:background fluorescence level is indicated by the bell curve. The expression level of the 
peptide-binding module-FP is indicated by the green gradient. Signal is indicated by a green 
band localizing to the bud neck of S. cerevisiae, while background is indicated by the disperse 
green in the cytoplasm. The black arrow points to Cdc12 under conditions where 
signal:background is optimal. 
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